by nikki mann | Jun 19, 2018 | News
SHIONOGI INVESTS IN NEMESIS TECHNOLOGY Japanese Pharma Company Joins £1.4M Seed Funding Round for Nemesis Bioscience Nemesis Bioscience today announced the completion of a Seed funding round of £1.4M from a syndicate of new investors including Shionogi & Co Ltd,...
by nikki mann | Apr 12, 2018 | News
Our new building is starting to take shape now, ready for the opening in October. The Milner Therapeutics Institute will have research laboratories within the Capella Building, which is on the Cambridge Biomedical Campus. The laboratories will house research...
by nikki mann | Jan 23, 2018 | News
London and Cambridge, UK 23 January 2018 – LifeArc®, the UK-based medical research charity and the Milner Therapeutics Institute at the University of Cambridge today announced a new partnership to identify and validate new drug targets in immuno-oncology and...
by nikki mann | Nov 8, 2017 | News
We are privileged to receive the Medical Advancement Institute of the Year award from AI Global Media. The award is in recognition of our global alliance, which we have increased from 6 organisations in 2015 to 65 organisations in 2017. Our alliance enables...
